Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race

Ganesh M. Babulal; Sanne Franzen; Erin L. Abner; Jade Emily Smith; Esther van den Berg; Monica Rivera Mindt; Rozermarijn Lidewij van Bruchem-Visser; Lon S. Schneider; Niels D. Prins; Janne M. Papma

doi:https://doi.org/10.1002/alz.12611

Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race

Ganesh M. Babulal, Sanne Franzen, Erin L. Abner, Jade Emily Smith, Esther van den Berg, Monica Rivera Mindt, Rozermarijn Lidewij van Bruchem-Visser, Lon S. Schneider, Niels D. Prins, Janne M. Papma

Research output: Contribution to journal › Letter › Academic › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	867-868
Number of pages	2
Journal	Alzheimer's and Dementia
Volume	18
Issue number	4
Early online date	2022
DOIs	https://doi.org/10.1002/alz.12611
Publication status	Published - Apr 2022

Access to Document

https://doi.org/10.1002/alz.12611

Cite this

@article{e5bd258e2a794854bd5798f0ff5b5a99,

title = "Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race",

author = "Babulal, {Ganesh M.} and Sanne Franzen and Abner, {Erin L.} and Smith, {Jade Emily} and {van den Berg}, Esther and Mindt, {Monica Rivera} and {van Bruchem-Visser}, {Rozermarijn Lidewij} and Schneider, {Lon S.} and Prins, {Niels D.} and Papma, {Janne M.}",

note = "Funding Information: SF and JMP report a grant from The Netherlands Organisation for Health Research and Development/Alzheimer's Nederland (ZonMw Memorabel; grant number 733050834). JES reports a personal James B. Reynolds scholarship for foreign study. LSS reports a grant from NIH (P30 AG066530). GMB reports grants from NIH/NIA (R01AG068183, R01AG067428, A2021142S) and the BrightFocus Foundation (A2021142S). MRM is supported by grants from the NIA/NIH (R13 AG071313‐01, R01AG065110‐01A1, NIH/NIA 5U19AG024904‐14, NIH/NIA R01AG066471‐01A1), NIH/NIMH (U24MH100931‐03), NIH/NIA (5R24AG065163), National Science Foundation, the Genentech Health Equity 2020 Fund (G‐89294), and the Alzheimer's Association (AARGD‐16‐446038).",

year = "2022",

month = apr,

doi = "https://doi.org/10.1002/alz.12611",

language = "English",

volume = "18",

pages = "867--868",

journal = "Alzheimer's and Dementia",

issn = "1552-5260",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Diversity in Alzheimer's disease drug trials

T2 - Reflections on reporting and social construction of race

AU - Babulal, Ganesh M.

AU - Franzen, Sanne

AU - Abner, Erin L.

AU - Smith, Jade Emily

AU - van den Berg, Esther

AU - Mindt, Monica Rivera

AU - van Bruchem-Visser, Rozermarijn Lidewij

AU - Schneider, Lon S.

AU - Prins, Niels D.

AU - Papma, Janne M.

N1 - Funding Information: SF and JMP report a grant from The Netherlands Organisation for Health Research and Development/Alzheimer's Nederland (ZonMw Memorabel; grant number 733050834). JES reports a personal James B. Reynolds scholarship for foreign study. LSS reports a grant from NIH (P30 AG066530). GMB reports grants from NIH/NIA (R01AG068183, R01AG067428, A2021142S) and the BrightFocus Foundation (A2021142S). MRM is supported by grants from the NIA/NIH (R13 AG071313‐01, R01AG065110‐01A1, NIH/NIA 5U19AG024904‐14, NIH/NIA R01AG066471‐01A1), NIH/NIMH (U24MH100931‐03), NIH/NIA (5R24AG065163), National Science Foundation, the Genentech Health Equity 2020 Fund (G‐89294), and the Alzheimer's Association (AARGD‐16‐446038).

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85124536992&partnerID=8YFLogxK

U2 - https://doi.org/10.1002/alz.12611

DO - https://doi.org/10.1002/alz.12611

M3 - Letter

C2 - 35142024

SN - 1552-5260

VL - 18

SP - 867

EP - 868

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

IS - 4

ER -

Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race

Access to Document

Other files and links

Cite this